Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
33%
Ph phase_3
3
50%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(5)
Completed(1)

Detailed Status

Not yet recruiting3
Recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 33 (50.0%)

Trials by Status

completed117%
not_yet_recruiting350%
recruiting233%

Recent Activity

2 active trials
Showing 5 of 6
recruitingphase_3

A PAN-USR TB Multi-Center Trial

NCT06905522
recruitingphase_2

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

NCT06114628
not_yet_recruitingphase_3

Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

NCT07163143
not_yet_recruitingphase_2

Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

NCT07129629
not_yet_recruitingphase_3

Ultra-Short Regimen for Elderly DS-TB

NCT07076225
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06905522Phase 3

A PAN-USR TB Multi-Center Trial

Recruiting
NCT06114628Phase 2

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

Recruiting
NCT07163143Phase 3

Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

Not Yet Recruiting
NCT07129629Phase 2

Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

Not Yet Recruiting
NCT07076225Phase 3

Ultra-Short Regimen for Elderly DS-TB

Not Yet Recruiting
NCT02457208Phase 1

PK Study of Anti-TB Drugs

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6